AzTrials
AzTrials

Central Venous CatheterCVC-TIPNCT07291869

Central Venous Catheter Placement With Thoracic Ultrasound and Intracavity ECG Positioning

A study testing Intracavity ECG and Thoracic point of care ultrasound in people with Central Venous Catheter and Point of Care Ultrasound (POCUS), run by York Teaching Hospitals NHS Foundation Trust at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this interventional study is to assess the feasibility of two bedside techniques for confirming central venous catheter (CVC) placement and detecting complications: Intracavity ECG monitoring to confirm internal jugular vein CVC tip position. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Intracavity ECG and Thoracic point of care ultrasound
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteUnited Kingdom
Study dates
15 May 2026to Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult (aged ≥ 18 years)
  • Admitted, or planned for admission, to critical care
  • Requiring central venous catheter insertion as a part of their usual care
  • Suitable for both right or left internal jugular vein insertion

Who cannot join

  • Previously randomised into CVC-TIP
  • Atrial fibrillation on 12-lead ECG
  • Cardiovascular instability, defined as
  • Noradrenaline dose > 0.5mcg/kg/min
  • Rapidly escalating doses of vasopressors / inotropes
  • Difficulty in obtaining thoracic ultrasound images due to either
Show all 14Show fewer
  • Weight > 120kg
  • Existing pneumothorax (either side)
  • Subcutaneous emphysema
  • Wounds / dressing over anterior chest wall
  • Existing pacemaker
  • Non-English speaking participants
  • Death perceived as imminent
  • Any other reason as determined by treating clinician

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Andrew Chamberlain, MBChB contact

+441904 631313

andrew.chamberlain8@nhs.net

Joseph Carter, MBChB contact

+441904 631313

joseph.carter4@nhs.net

United Kingdom1 site, 1 recruiting
  • York and Scarborough Teaching Hospitals NHS Foundation Trust

    York, North Yorkshire, YO31 8HE

    Andrew Chamberlain, MBChB, +441904 631313, andrew.chamberlain8@nhs.net

    Joseph Carter, MBChB, +441904 631313, joseph.carter4@nhs.net

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Randomised Feasibility Study of Real-time Intracavity ECG and Thoracic Ultrasound for Central Venous Catheter Tip Confirmation in Critical Care

The goal of this interventional study is to assess the feasibility of two bedside techniques for confirming central venous catheter (CVC) placement and detecting complications:

  • Intracavity ECG monitoring to confirm internal jugular vein CVC tip position.
  • Thoracic point-of-care ultrasound (POCUS) to rule out pneumothorax following CVC insertion.
Read more

Participants who require an internal jugular CVC as part of their routine care and meet all inclusion and no exclusion criteria will be randomised to receive either:

  • Standard care, or
  • The intervention, consisting of intracavity ECG guidance and thoracic POCUS. The CVC will be inserted either on the left or right side of the neck.

All participants will undergo a post-procedure chest X-ray regardless of study arm, to allow comparison of the intervention methods with standard care.

Read the detailed description

Central venous catheters (CVCs) are commonly inserted in critically ill patients to enable the administration of medications, fluids, and monitoring. Following insertion, it is standard practice to perform a chest X-ray (CXR) to confirm correct catheter tip position and exclude complications such as pneumothorax. However, reliance on post-procedure radiography can delay verification of line position, increase patient radiation exposure, and contribute to workflow inefficiency.

Alternative bedside techniques have been proposed to improve the speed and safety of CVC verification. Intracavity electrocardiography (IC-ECG) uses the patient's cardiac electrical activity to confirm the catheter tip's location in real time. When the catheter tip approaches the cavoatrial junction, a characteristic increase in P-wave amplitude is observed, allowing for accurate placement without the need for immediate imaging. Thoracic point-of-care ultrasound (POCUS) has been shown to be an effective method for detecting pneumothorax following CVC insertion.

This single-centre, prospective, randomised feasibility study will evaluate the combined use of intracavity ECG for tip confirmation and thoracic POCUS for pneumothorax exclusion in patients requiring internal jugular CVC insertion. Eligible participants will be randomised to receive either:

  • Standard care (ultrasound-guided insertion with post-procedure CXR), or
  • The intervention, consisting of ultrasound-guided insertion supplemented with intracavity ECG confirmation and thoracic POCUS assessment, followed by a post-procedure CXR for comparison.

The primary objective is to determine the feasibility of implementing these combined techniques within a critical care environment, including assessment of recruitment, protocol adherence, and completeness of data acquisition. Secondary outcomes include the accuracy of IC-ECG and POCUS compared to CXR for tip position and pneumothorax detection, and the time required to confirm line placement.

The findings will inform the design of a future multi-centre study to assess diagnostic accuracy, cost-effectiveness, and potential to replace routine post-procedure chest X-ray in appropriate clinical settings.

Being tested
Intracavity ECG, Thoracic point of care ultrasound
Keywords
Intracavity ECG, POCUS, IC-ECG, Thoracic point of care ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intracavity ECGDevice

    Also called IC-ECG

    Vygon PILOT TLS (Tip Location System) used to provide intracavity ECG monitoring for central venous catheter tip positioning.

  • Thoracic point of care ultrasoundDiagnostic test

    Also called POCUS

    Thoracic point of care ultrasound used to scan both lung fields to rule out pneumothorax

Study groups in NCT07291869
Study groupRoleWhat they receive
LEFT internal jugular vein CVC with IC-ECG and thoracic POCUSActive comparatorLEFT internal jugular vein CVC with IC-ECG and thoracic POCUS. Post procedure chest x-ray.
Receives: Device: Intracavity ECG; Diagnostic Test: Thoracic point of care ultrasound
RIGHT internal jugular vein CVC with IC-ECG and thoracic POCUSActive comparatorRIGHT internal jugular vein CVC with IC-ECG and thoracic POCUS. Post procedure chest x-ray.
Receives: Device: Intracavity ECG; Diagnostic Test: Thoracic point of care ultrasound
Standard careNo interventionLeft or right internal jugular vein CVC. Post procedure CXR.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment Rate

    How quickly the recruitment target can be achieved within the planned study period

    Measured: 12-month recruitment window

  2. Protocol adherence

    The number of protocol deviations for all 3 arms

    Measured: 12-month recruitment window

  3. Data completeness

    The percentage complete data records for each enrolment

    Measured: 12-month recruitment window

  4. Training requirements

    Feasibility of delivering the required clinician training to ensure safe and consistent implementation of the study protocol

    Measured: 12-month recruitment window

  5. Technical success rate

    How successful the intervention is when compared to the gold standard chest x-ray

    Measured: 12-month recruitment window

  6. Time taken for confirmation of central venous catheter tip positioning

    Time taken from start of procedure to successful confirmation (both using intracavity ECG and chest x-ray)

    Measured: 12-month recruitment window

Secondary outcomes (5)
  1. Rate of catheter malposition

    The incidence of central venous catheter malposition on intracavity-ECG and chest x-ray in all treatment arms

    Measured: 12-month recruitment window

  2. Incidence of complications

    Rate of procedure-related complications occurring during or immediately after insertion.

    Measured: Insertion to 48 hours post-procedure

  3. Inter-operator reliability of IC-ECG and POCUS findings

    Measurement of inter-operator reliability for IC-ECG and POCUS interpretations, using blinded independent review of stored image and waveform data.

    Measured: Images stored during the procedure and reviewed up to 28 days post-procedure

  4. Proportion of cases which would avoid post-insertion CXR

    Proportion of catheter insertions where post-procedural a chest x-ray would not be required based on the study criteria

    Measured: 12-month recruitment window

  5. Operator confidence

    Operator survey for each procedure in the intervention arm, which includes a 5-point Likert confidence scale from "Not Confident" to "Extremely Confident"

    Measured: Completed within 24 hours of catheter insertion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2025
  2. Study start15 May 2026
  3. Primary completionOct 2027 (estimated)
  4. Study completionOct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pragmatic, single-centre, open, randomised control study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07291869
Sponsor's protocol ID
360875
Other IDs
360875
Acronym
CVC-TIP
Status last verified
May 2026
First submitted
21 Nov 2025
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Anonymised individual participant data will not be publicly available. Data may be shared on reasonable request with approval from the trial steering committee and subject to a signed data sharing agreement. Shared data will include de-identified procedural and clinical outcome information and may be used for secondary analyses or meta-analyses.

Publications

  • Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91. doi: 10.1093/bja/85.2.188. No abstract available.

    PubMed 10992821
  • Kang M, Bae J, Moon S, Chung TN. Chest radiography for simplified evaluation of central venous catheter tip positioning for safe and accurate haemodynamic monitoring: a retrospective observational study. BMJ Open. 2021 Jan 4;11(1):e041101. doi: 10.1136/bmjopen-2020-041101.

    PubMed 33397666

Questions about this trial

What is this clinical trial studying?

A study testing Intracavity ECG and Thoracic point of care ultrasound in people with Central Venous Catheter and Point of Care Ultrasound (POCUS), run by York Teaching Hospitals NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andrew Chamberlain, MBChB (+441904 631313, andrew.chamberlain8@nhs.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment Rate (time frame: 12-month recruitment window). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07291869, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in